We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Submit completed applications by the deadline of 17 February 2023
In order to be considered for a European LEAD Grant award, your application must be received by the deadline noted above. Grant recipients will be announced in March 2023.
Please answer the following questions and provide as much detail as possible describing the opportunity for European LEAD Grant funding. Please feel free to submit any supporting documentation that would be helpful to explain the proposal:
Any additional relevant information or support material may be included with the application.
All grantees will be required to submit a progress report six months from receipt of funding on activities and achievements to-date.
Thank You
Popular search terms:
Americas
Asia Pacific
Middle East
Europe